Non-alcoholic fatty liver disease (NAFLD), characteristically similar to metabolic dysfunction-associated fatty liver disease, has a worldwide prevalence of 25%. It is rapidly becoming the number one cause of cirrhosis and liver cancer.
Weight loss is first-line therapy in NAFLD treatment. A 7-10% reduction in weight improved:
Weight reduction associated with a calorie deficit of 750-1000 Calories/day or a 30% calorie reduction from current intake can improve:
Exercise interventions, based on at least 150 minutes of moderate exercise, including aerobic and resistance training weekly, can significantly improve:
For optimal outcomes, weight loss goals should be combined with daily exercise and a healthy Mediterranean-style diet. A systemic review and meta-analysis showed that combining exercise with diet interventions improved ALT, AST, GGT, and HOMA-IR parameters better than either intervention alone. The analysis included 3,280 subjects 33-61 years of age with varying degrees of NAFLD.
Author, year |
Type of intervention |
Supervision |
Duration |
Intervention group protocol |
Control group protocol |
Outcomes |
Changes post intervention |
|
Al-Jiffri, 2013 |
Exercise + Diet |
No |
13 weeks |
EX: 5-minute warm-up phase on the treadmill. Endurance training session for 30 minutes. 5-minute recovery |
No intervention |
liver enzymes, HOMA-IR, insulin |
↓BMI*☨ |
|
↓ALP, ALT, AST, |
|
|||||||
GGT*☨ |
|
|||||||
↓HOMA-IR*☨ |
||||||||
D: low calorie diet (1200 kcal): 15% as protein, 30 to 35% as fat and 50 to 55% as CHO |
|
|||||||
Arab, 2017 |
Exercise + Diet |
No |
9 weeks |
Eight lifestyle sessions about healthy eating and regular physical activity for 5 days/week |
Usual care |
Weight, BMI, other body composition measures |
↓Weight* |
|
↓BMI*☨ |
|
|||||||
↓Abdominal circumference* |
|
|||||||
↓Lean body mass* |
|
|||||||
↓Percent of body fat* |
|
|||||||
Cheng, 2017 |
Exercise + Diet |
Yes |
37 weeks |
AER: Progressive aerobic training program. 5 min warm-up, 30–60 minutes session, 5 minutes cool-down. 65 to 70% of VO2max. |
No intervention |
HFC, HbA1c, insulin sensitivity, body composition, total cholesterol, liver enzymes |
↓HFC*☨ |
|
↓Weight (only in AED group) |
|
|||||||
↓FM☨ |
|
|||||||
↓fat% ☨ |
|
|||||||
↓HbA1c (only AED group) |
||||||||
D: 30–40%of the total daily energy intake. 37–40% CHO, 9–13 gr as fiber, 35–37% fat, 25–27% protein. Maintain personal physical activities |
|
|||||||
AED: AER + D protocols. |
|
|||||||
Dong, 2016 |
Exercise + Diet |
Yes |
104 weeks |
D: Negative calorie balance of (25–30 c/kg/d) for overweight and obese. Neutral calorie balance (30–35 c/kg/d) for normal BMI. 20–30% fat, 15–20% protein, 50–60% CHO |
Lifestyle counseling |
Weight, liver enzymes, IHL content, lipid profile, fasting plasma glucose |
↓Weight* |
|
—BMI |
|
|||||||
↓NAFLD fibrosis score* |
|
|||||||
↓ALT*, —AST, —GGT |
|
|||||||
↓TC*, —TG, |
|
|||||||
HDL*, LDL* |
||||||||
EX: Favorite aerobic exercise or activity, moderate intensity (60–80% of heart rate) to vigorous (>80%). |
|
|||||||
Eckard, 2013 |
Exercise + Diet |
Yes |
26 weeks |
D: Nutrition prescription based on individualized calorie needs subtracting 500 kcal/day and macronutrient distribution |
Standard care |
Liver biopsy (NAS), body composition, lipid profile, liver enzymes, HbA1c, glucose, insulin |
—Weight |
|
—Fat mass % |
|
|||||||
↓NAS* |
|
|||||||
↓ALT, AST* |
|
|||||||
—Fasting glucose |
|
|||||||
—Insulin |
||||||||
EX: Education about exercise based on ACSM’s recommendations. |
|
|||||||
Katsagoni, 2018 |
Exercise + Diet |
Self-monitoring |
26 weeks |
Energy restriction regimen. 45% CHO, 20% protein, 35% lipids. 1500 kcal women, 1800 kcal men. |
Energy restriction regimen. 45% CHO, 20% protein, 35% lipids. 1500 kcal women, 1800 kcal men + general written dietary guidelines for a healthy lifestyle. |
Weight, BMI, WC, ALT, GGT, Liver stiffness, NAFLD fibrosis score, glucose, insulin, HOMA-IR, lipid profile |
↓Weight*☨ |
|
↓BMI*☨ |
|
|||||||
↓Liver stiffness*☨ |
|
|||||||
↓ALT only in MLG group* |
||||||||
MDG: Seven 60-min small group sessions about improving diet quality and energy restriction held every 2 weeks for the first 2 months and every month for the next 4 months. |
|
|||||||
MLG: MDG + enhancing activity through a moderate–vigorous intensity physical activity program as well as for optimal sleep duration and mid-day rest. |
||||||||
—HOMA-IR |
|
|||||||
↓LDL only MDG group* |
|
|||||||
—blood pressure |
|
|||||||
↑Adherence to intervention* |
|
|||||||
Promrat, 2010 |
Exercise + Diet |
No |
48 weeks |
Weight loss intervention based on different strategies used successfully in other trials (diet, exercise, and behavior changes) |
Small group sessions providing basic education about NASH, healthy eating, physical activity, and weight control. |
Weight, BMI, ALT, AST, TC, LDL, HDL, TG, glucose, HbA1c, insulin, HOMA |
↓Weight*☨ |
|
↓WC*☨ |
|
|||||||
↓NAS*☨ |
|
|||||||
↓ALT*☨ |
|
|||||||
— HOMA, insulin, HbA1c |
|
|||||||
Sun, 2012 |
Exercise + Diet |
No |
12 weeks |
Diet: 30% fat, 15% proteins and 55% carbohydrates, including 5% sugar. Energy intake: 25–30 kcal/kg. EX: walking, jogging, stair climbing and physical exercise, 23 (METs)•h/week (physical activity) + 4 METs•h/week (exercise). |
Basic education about NAFLD and principles of healthy eating, physical activity, and weight control |
Weight, BMI, WC, ALT, AST, GGT, TC, TG, fasting glucose, HOMA-IR, visceral fat area |
↓Weight*☨ |
|
↓BMI *☨ |
|
|||||||
↓WC*☨ |
|
|||||||
↓ ALT*☨ |
|
|||||||
↓ AST, GGT* |
|
|||||||
— TG, TC, fasting glucose |
|
|||||||
|
||||||||
|
* Statistically significant within group,
☨ statistically significant compared to control group,
↓ decreased, ↑ increased, — no change. Abbreviations: ACSM: American college of sports medicine, AED: aerobic exercise + diet, AER: aerobic, ALP: alkaline phosphatase, ALT: alanine transferase, AST: aspartate transferase, BMI: body mass index, CHO: carbohydrates, D: diet, EX: exercise, FM: fat mass, GGT: gamma glutamyl transferase, HbA1c: glycated hemoglobin, HDL: high density lipoprotein, HFC: hepatic fat content, MDG: Mediterranean diet group, MET: metabolic equivalent of task MLG: Mediterranean lifestyle group, TC: total cholesterol, TG: triglycerides, VFA: visceral fat area,VO2 max: maximum oxygen consumption, WC: waist circumference.
Fernandez, Tiziana et al. “Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.” PloS one vol. 17,2 e0263931. 17 Feb. 2022, doi:10.1371/journal.pone.0263931 https://creativecommons.org/licenses/by/4.0/